Additionally, it has been shown that such a reduction in insulin biosynthesis and secretion together with a reduction in PDX-1 and MafA is preserved by mitigating pancreatic β-cell failure with insulin preparation or SGLT2 inhibitors, especially in the early stage of diabetes mellitus [86,87,88,89,90]. Here, MAFA is linked to diabetes mellitus.